Skip to content

Nsequence

Country not established

Devices
1

What Nsequence makes

Nsequence manufactures the MAVEN PRO, a medical device designed for next-generation genomic sequencing and analysis in clinical and research settings. It supports high-throughput DNA and RNA sequencing workflows, enabling precise identification and quantification of genetic material for diagnostic and research applications.

The MAVEN PRO is classified as a Class II device under FDA regulations and has been authorised through the 510(k) clearance process. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Maven Pro Ref K130242

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Nsequence have in the registry?

The registry currently lists 1 device for Nsequence. Devices recorded under merged duplicate company entries are counted once.

Which registries list Nsequence's devices?

Among its 1 most recently registered device, Nsequence has devices listed in FDA 510(k) (1 device).

What risk classes do Nsequence's devices fall under?

Among its 1 most recently registered device, the classes recorded for Nsequence's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Nsequence in the registry?

The most recently registered devices listed for Nsequence include MAVEN PRO.

Generated automatically from registry data and not verified by a human reviewer.